Merck KGaA, Novartis lead race to launch first MS pill

02/12/2009 | Bloomberg

Novartis AG and Merck KGaA are the front-runners in the race to launch the first oral medicine for multiple sclerosis, with both planning to seek regulatory approval this year for their drugs. Not far behind are Teva Pharmaceutical Industries, Biogen Idec and Sanofi-Aventis, which are expected to release their versions no earlier than 2012.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ